MRI影像组学预测肌层浸润性膀胱癌无病生存期不良:回顾性队列研究结果
该回顾性队列纳入91例T2-T4aN0M0期、无免疫治疗史的肌层浸润性膀胱癌患者,基于TP53突变状态联合肿瘤突变负荷进行分子风险分层,高风险组2年无病生存期显著更差(HR=4.36,95%CI 1.82-10.44,P<0.001)。LASSO筛选出5个影像组学特征构建列线图,在测试队列中预测该分层的AUC为0.909(95%CI 0.789-0.991),准确率0.889(95%CI 0.708-0.977)。
要点
- TP53突变且TMB低于均值的MIBC患者2年DFS显著更差(HR=4.36)。
- LASSO筛选出5个与分子风险分层相关的MRI影像组学特征。
- 列线图在测试队列预测风险分层的AUC为0.909、准确率0.889。
核心结论
- 基于TP53突变状态联合TMB水平的分子风险分层与MIBC的DFS强相关,影像组学特征可有效预测该分层,为临床决策提供有价值的信息。
研究设计与样本
- 回顾性队列研究,纳入91例T2-T4aN0M0期、无免疫治疗史的MIBC患者,分析DNA测序数据、预后信息与影像组学特征,以Cox回归基于TP53突变状态和TMB水平进行风险分层,以LASSO筛选影像组学特征并用逻辑回归构建列线图,在测试队列中以ROC、HL检验、CIC和DCA评估。
诊断标准与关键数值
- 91例中平均TMB值为3.3 mut/Mb,60例存在TP53突变;TP53突变且TMB低于均值者被定为高风险,其2年DFS显著更差(HR=4.36,95%CI 1.82-10.44,P<0.001);LASSO筛选出5个与风险分层相关的影像组学特征;测试队列中列线图预测该分层的AUC为0.909(95%CI 0.789-0.991),准确率为0.889(95%CI 0.708-0.977)。
临床应用与阅片要点
- 作者认为影像组学特征可有效预测基于TP53突变状态联合TMB水平的分子风险分层,并可为临床决策提供有价值的信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop an MRI radiomic nomogram capable of identifying muscle invasive bladder cancer (MIBC) patients with high-risk molecular characteristics related to poor 2-year disease-free survival (DFS).
METHODS: We performed a retrospective analysis of DNA sequencing data, prognostic information, and radiomics features from 91 MIBC patients at stages T2-T4aN0M0 without history of immunotherapy. To identify risk stratification, we employed Cox regression based on TP53 mutation status and tumor mutational burden (TMB) level. Radiomics signatures were selected using the least absolute shrinkage and selection operator (LASSO) to construct a nomogram based on logistic regression for predicting the stratification in the training cohort. The predictive performance of the nomogram was assessed in the testing cohort using receiver operator curve (ROC), Hosmer-Lemeshow (HL) test, clinical impact curve (CIC), and decision curve analysis (DCA).
RESULTS: Among 91 participants, the mean TMB value was 3.3 mut/Mb, with 60 participants having TP53 mutations. Patients with TP53 mutations and a below-average TMB value were identified as high risk and had a significantly poor 2-year DFS (hazard ratio = 4.36, 95% CI 1.82-10.44, P < 0.001). LASSO identified five radiomics signatures that correlated with the risk stratification. In the testing cohort, the nomogram achieved an area under the ROC curve of 0.909 (95% CI 0.789-0.991) and an accuracy of 0.889 (95% CI 0.708-0.977).
CONCLUSION: The molecular risk stratification based on TP53 mutation status combined with TMB level is strongly associated with DFS in MIBC. Radiomics signatures can effectively predict this stratification and provide valuable information to clinical decision-making.
引用
- Fan ZC, Zhang L, Yang GQ, et al. MRI radiomics for predicting poor disease-free survival in muscle invasive bladder cancer: the results of the retrospective cohort study. Abdom Radiol (NY). 2023. PMID: 37804424. doi:10.1007/s00261-023-04028-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。